Lysvik EK, Tulipan AJ, Haakensen VD, Revheim MR, Emblem KE, Hjørnevik T (2026)
Quantitative [¹⁸F]PSMA-1007 PET in Treatment Response Monitoring of Brain Metastases from Non-small Cell Lung Cancer
Mol Imaging Biol (in press)
DOI 10.1007/s11307-026-02104-w, PubMed 42026421

Sommervoll FÅ, Horndalsveen H, Sommervoll DE, Koivonen J, Halvorsen TO, Grønberg BH, Aanerud M, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Barrera G, Bjaanæs MM, Haakensen V, Öjlert Å, Oselin K, Helland Å, Madebo T (2026)
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?
Acta Oncol, 65, 232-240
DOI 10.2340/1651-226X.2026.45040, PubMed 41854264

Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Van Den Heuvel MM, Vercauter P, Smit HJM, Solomon B, Chander P, Qiao Y, Faria J, Girard N (2026)
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy
Clin Transl Radiat Oncol, 58, 101138
DOI 10.1016/j.ctro.2026.101138, PubMed 41809542